ArticleOncotarget2022

HDAC inhibitors suppress protein poly(ADP-ribosyl)ation and DNA repair protein levels and phosphorylation status in hematologic cancer cells: implications for their use in combination with PARP inhibitors and chemotherapeutic drugs.

Benigno C Valdez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.